» Articles » PMID: 27108412

MUC1 Gene Polymorphisms Are Associated with Serum KL-6 Levels and Pulmonary Dysfunction in Pulmonary Alveolar Proteinosis

Overview
Publisher Biomed Central
Specialty General Medicine
Date 2016 Apr 25
PMID 27108412
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: KL-6, a human MUC1 mucin, is a sensitive biomarker for interstitial lung diseases including pulmonary alveolar proteinosis (PAP). A correlation between MUC1 gene single nucleotide polymorphism (SNP) rs4072037 genotype and serum KL-6 levels has been reported. This study was aimed at investigating the correlation between MUC1 SNP genotype, severity of disease and disease outcome in PAP.

Methods: Twenty four patients with PAP and 30 healthy volunteers were studied. MUC1 rs4072037 was detected by using a real-time polymerase chain reaction (RT-PCR). Genotyping was performed by pyrosequencing. KL-6 levels were measured in serum by Nanopia KL-6 assay (SEKISUI Diagnostics).

Results: The frequency of MUC1 rs4072037 alleles was significantly different between PAP patients and healthy volunteers (PAP, A/A 46%, A/G 54%, G/G 0%; healthy controls, A/A 30%, A/G 40%, G/G 30%; p = 0.013). Serum KL-6 levels were significantly higher in PAP patients than in controls (p < 0.0001), and significantly higher in PAP patients with A/A genotype than in those with A/G genotype (p = 0.007). Patients with A/A genotype had higher alveolar-arterial oxygen difference (A-aDO2) and lower DLco compared to those with A/G genotype (p = 0.027 and p = 0.012, respectively). Multivariate analysis, Kaplan-Meier analysis and C statistics showed that the rs4072037 A/A genotype was associated with higher rate of disease progression (HR: 5.557, p = 0.014).

Conclusions: MUC1 rs4072037 A/A genotype is associated with more severe pulmonary dysfunction and a higher rate of disease progression in PAP patients.

Citing Articles

Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis.

Lettieri S, Bonella F, Marando V, Franciosi A, Corsico A, Campo I Eur Respir Rev. 2024; 33(173).

PMID: 39142709 PMC: 11322829. DOI: 10.1183/16000617.0064-2024.


Coexistence of Autoimmune Pulmonary Alveolar Proteinosis With Small Cell Lung Cancer in a Man Presenting With Acute Onset Respiratory Failure.

Papaioannou O, Koulousousa E, Karampitsakos T, Tzouvelekis A Cureus. 2023; 15(11):e48330.

PMID: 38060701 PMC: 10698294. DOI: 10.7759/cureus.48330.


Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF): Protocol for a Multicenter Prospective Study.

Rzepka-Wrona P, Skoczynski S, Piotrowski W, Jassem E, Ziora D, Barczyk A JMIR Res Protoc. 2023; 12:e44802.

PMID: 37976081 PMC: 10692886. DOI: 10.2196/44802.


Serum KL-6 as a Candidate Predictor of Outcome in Patients with SARS-CoV-2 Pneumonia.

Kattner S, Sutharsan S, Berger M, Limmer A, Jehn L, Herbstreit F J Clin Med. 2023; 12(21).

PMID: 37959236 PMC: 10648641. DOI: 10.3390/jcm12216772.


Serum KL-6 levels predict clinical outcomes and are associated with polymorphism in Japanese patients with COVID-19.

Azekawa S, Chubachi S, Asakura T, Namkoong H, Sato Y, Edahiro R BMJ Open Respir Res. 2023; 10(1).

PMID: 37230764 PMC: 10230347. DOI: 10.1136/bmjresp-2023-001625.


References
1.
Bonella F, Bauer P, Griese M, Ohshimo S, Guzman J, Costabel U . Pulmonary alveolar proteinosis: new insights from a single-center cohort of 70 patients. Respir Med. 2011; 105(12):1908-16. DOI: 10.1016/j.rmed.2011.08.018. View

2.
Stahel R, Gilks W, Lehmann H, Schenker T . Third International Workshop on Lung Tumor and Differentiation Antigens: overview of the results of the central data analysis. Int J Cancer Suppl. 1994; 8:6-26. DOI: 10.1002/ijc.2910570704. View

3.
Kupcinskas J, Wex T, Link A, Bartuseviciute R, Dedelaite M, Kevalaite G . PSCA and MUC1 gene polymorphisms are associated with gastric cancer and pre-malignant gastric conditions [corrected]. Anticancer Res. 2014; 34(12):7167-75. View

4.
Bonella F, Ohshimo S, Miaotian C, Griese M, Guzman J, Costabel U . Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis. Orphanet J Rare Dis. 2013; 8:53. PMC: 3629718. DOI: 10.1186/1750-1172-8-53. View

5.
Ng W, Loh A, Teixeira A, Pereira S, Swallow D . Genetic regulation of MUC1 alternative splicing in human tissues. Br J Cancer. 2009; 99(6):978-85. PMC: 2538764. DOI: 10.1038/sj.bjc.6604617. View